about
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.Molecular Markers in Low-Grade Glioma-Toward Tumor ReclassificationInhibition of glioblastoma malignancy by Lgl1.The future of high-grade glioma: Where we are and where are we going.IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas.Prognostic microRNAs in high-grade glioma reveal a link to oligodendrocyte precursor differentiation.A model of a patient-derived IDH1 mutant anaplastic astrocytoma with alternative lengthening of telomeresIsocitrate dehydrogenase mutations in gliomasPI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patientsIdentification of high risk anaplastic gliomas by a diagnostic and prognostic signature derived from mRNA expression profiling.Whole Exome- and mRNA-Sequencing of an AT/RT Case Reveals Few Somatic Mutations and Several Deregulated Signalling Pathways in the Context of SMARCB1 Deficiency.Network analysis of microRNAs, transcription factors, target genes and host genes in human anaplastic astrocytoma.Phosphohistone H3 (pHH3) is a prognostic and epithelial to mesenchymal transition marker in diffuse gliomas.Diffusely infiltrating astrocytomas: pathology, molecular mechanisms and markers.Clinical Neuropathology practice news 2-2014: ATRX, a new candidate biomarker in gliomasMutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression.Classification of adult diffuse gliomas by molecular markers-a short review with historical footnote.Anaplastic astrocytoma: prognostic factors and survival in 4807 patients with emphasis on receipt and impact of adjuvant therapy.Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups.Reclassification of Mixed Oligoastrocytic Tumors Using a Genetically Integrated Diagnostic Approach.Adaptive Evolution of the GDH2 Allosteric Domain Promotes Gliomagenesis by Resolving IDH1R132H-Induced Metabolic Liabilities.Current therapeutic approaches to diffuse grade II and III gliomas.The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma.Effects of tumor grade and dexamethasone on myeloid cells in patients with glioma
P2860
Q27853175-BD5D2FF3-4166-4F43-A009-08E5EC9B639FQ28383205-F05F907D-D826-4964-943F-70A8FC16EDA1Q34957420-646B7F91-BE32-44C3-8AF7-82690D6502F4Q35114090-2AEF7B57-0DA4-4492-AAE4-B5F64508EDFCQ35204658-21FE3B82-E3CF-4567-8C0B-006FCF3A4DDFQ35376154-88C44C62-754B-481A-82E3-275CF99489C8Q36288179-2BF86E1C-13E3-4543-9EA1-784DE298757BQ36367409-7A97708E-E08A-42FB-8D8B-18D6853BB69AQ36402259-E15C0BB7-B62E-4166-A675-1A7C757B96C3Q36546750-B04DB7B9-4FD5-4D5E-AFA5-C7C5F1309610Q36657085-837F6C40-70BF-4251-852E-8BC87327E637Q37001046-E1C9CA31-F577-4ECD-A665-53A1369B88B6Q37564326-42B86402-5B43-46BA-8C92-956F079711EEQ38480437-8F1BBE5E-DE2C-43EE-9397-DA320B9BF9E8Q38535798-F1192DE0-1F0A-42F6-A5FF-B2939B010999Q38763202-C0BE724D-3777-46AE-A985-7C7FDBF0C105Q38995540-EDEAFF6F-22D7-4387-B8EC-A0D9D1B0237EQ39613251-95E8CDD6-07B7-4D58-BF81-A9CB912ABEACQ41201032-19AFA6CE-0F52-4FB8-B681-9C97D5D263D6Q47257739-E85AE501-F80F-4CF6-B5D1-F708A34B5740Q47989563-0F05E79C-4BB5-461D-86F0-46672A6EA9A9Q49317056-8F526079-9D39-4F21-84AC-D6C9C9C0A82DQ55104257-D6BD4CB9-4175-4FF9-A89B-E1CD550507CDQ58129521-3B1A7CD4-BA58-48E8-A581-C1B28DC87337
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The genetic landscape of anaplastic astrocytoma.
@ast
The genetic landscape of anaplastic astrocytoma.
@en
type
label
The genetic landscape of anaplastic astrocytoma.
@ast
The genetic landscape of anaplastic astrocytoma.
@en
prefLabel
The genetic landscape of anaplastic astrocytoma.
@ast
The genetic landscape of anaplastic astrocytoma.
@en
P2093
P2860
P50
P356
P1433
P1476
The genetic landscape of anaplastic astrocytoma.
@en
P2093
B Ahmed Rasheed
Christopher J Pirozzi
Patrick J Killela
Sian Jones
Zachary J Reitman
P2860
P304
P356
10.18632/ONCOTARGET.1505
P407
P577
2014-03-01T00:00:00Z